This site is intended for healthcare professionals only

In association with the Cardiorenal Forum

Articles

  • Injecting contrast medium

    Inorganic nitrate reduces contrast-induced nephropathy in high-risk patients

  • Man taking pill

    SGLT2i kidney outcome trial participants vs a real-world population

  • Patient in hospital

    Rare kidney diseases and kidney failure: a longitudinal analysis

  • Guidelines concept

    UPDATE: The 2024 KDIGO CKD Evaluation and Management Guidelines are here

  • SGLT2 inhibitors versus GLP-1 receptor agonists for renal patients: does it matter?

  • Pharmacist considering medications

    Novel antidiabetes drugs improve composite renal outcomes

  • Close-up of surgeon's face

    Long-term outcomes after conversion to belatacept

  • ECG trace

    Increased days in hospital after RAASi reduction

  • Nephrology research highlights 2023: Implications for clinical practice

alt

For the latest news and articles
Sign up to Renal Review newsletters

Subscribe